AAPG Stock Price Chart
AAPG Dividends
Ascentage Pharma Group International
$18.37
-1.97%
$-0.36
At close: Jul 20, 16:00:00 GMT-4
$18.65
1.56%
$0.28
Pre-market: Jul 21, 08:35:24 GMT-4
Back
Ascentage Pharma Group International (AAPG) Dividends
Key Stats
Prev.Close
$18.74
Open
$18.37
Day's Range
$18.37 - $18.65
52 week range
$16.36 - $48.45
Volume
1.1K
Avg.Volume
11.4K
Dividend yield
--
EPS (TTM)
-2.06
Market Cap
$1.7B
What is Ascentage Pharma Group Internat?
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. The company is headquartered in Suzhou, Jiangsu and currently employs 605 full-time employees. The company went IPO on 2019-10-28. The Company’s main business is engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus and certain age-related diseases. The Company’s main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918 and other products. The Company’s products are mainly used to address the major hematological malignancies, including chronic myeloid leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, acute lymphocytic leukemia, myelodysplastic syndrome, and multiple myeloma. The firm mainly conducts its business in the domestic market.
